Novel trends in celiac disease

Torsten Matthias, Sandra Neidhöfer, Sascha Pfeiffer, Kai Prager, Sandra Reuter, M. Eric Gershwin

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Celiac disease (CD) is one of the most common food intolerances in developed world. It affects genetically susceptible individuals and has severe consequences if it remains undiagnosed. A disease known for more than a century, it is still the focus for experts from various fields of research and development. Geneticists, pathologists, immunologists, food engineers and dieticians share their knowledge and expertise to improve the conditions of CD patients. With new insights in the pathomechanism of gluten processing and antigen presentation in CD, it was possible to improve the diagnostic antigen mimicking the primary epitope in CD. These celiac neo-epitopes are comprised of a complex of gliadin peptides crosslinked with transglutaminase (tTg). They are an early diagnostic marker for CD which occurs up to 6 months earlier than classical markers known to miss a certain amount of CD patients.

Original languageEnglish (US)
Pages (from-to)121-125
Number of pages5
JournalCellular and Molecular Immunology
Volume8
Issue number2
DOIs
StatePublished - Mar 2011

Fingerprint

Celiac Disease
Epitopes
Gliadin
Food
Transglutaminases
Nutritionists
Glutens
Antigen Presentation
Abdomen
Antigens
Peptides
Research

Keywords

  • celiac disease
  • celiac neo-epitope
  • diagnostic marker
  • gluten
  • tissue transglutaminase

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases
  • Immunology

Cite this

Matthias, T., Neidhöfer, S., Pfeiffer, S., Prager, K., Reuter, S., & Gershwin, M. E. (2011). Novel trends in celiac disease. Cellular and Molecular Immunology, 8(2), 121-125. https://doi.org/10.1038/cmi.2010.68

Novel trends in celiac disease. / Matthias, Torsten; Neidhöfer, Sandra; Pfeiffer, Sascha; Prager, Kai; Reuter, Sandra; Gershwin, M. Eric.

In: Cellular and Molecular Immunology, Vol. 8, No. 2, 03.2011, p. 121-125.

Research output: Contribution to journalArticle

Matthias, T, Neidhöfer, S, Pfeiffer, S, Prager, K, Reuter, S & Gershwin, ME 2011, 'Novel trends in celiac disease', Cellular and Molecular Immunology, vol. 8, no. 2, pp. 121-125. https://doi.org/10.1038/cmi.2010.68
Matthias T, Neidhöfer S, Pfeiffer S, Prager K, Reuter S, Gershwin ME. Novel trends in celiac disease. Cellular and Molecular Immunology. 2011 Mar;8(2):121-125. https://doi.org/10.1038/cmi.2010.68
Matthias, Torsten ; Neidhöfer, Sandra ; Pfeiffer, Sascha ; Prager, Kai ; Reuter, Sandra ; Gershwin, M. Eric. / Novel trends in celiac disease. In: Cellular and Molecular Immunology. 2011 ; Vol. 8, No. 2. pp. 121-125.
@article{b63ed9b4e44c450d8cc286630c7d3583,
title = "Novel trends in celiac disease",
abstract = "Celiac disease (CD) is one of the most common food intolerances in developed world. It affects genetically susceptible individuals and has severe consequences if it remains undiagnosed. A disease known for more than a century, it is still the focus for experts from various fields of research and development. Geneticists, pathologists, immunologists, food engineers and dieticians share their knowledge and expertise to improve the conditions of CD patients. With new insights in the pathomechanism of gluten processing and antigen presentation in CD, it was possible to improve the diagnostic antigen mimicking the primary epitope in CD. These celiac neo-epitopes are comprised of a complex of gliadin peptides crosslinked with transglutaminase (tTg). They are an early diagnostic marker for CD which occurs up to 6 months earlier than classical markers known to miss a certain amount of CD patients.",
keywords = "celiac disease, celiac neo-epitope, diagnostic marker, gluten, tissue transglutaminase",
author = "Torsten Matthias and Sandra Neidh{\"o}fer and Sascha Pfeiffer and Kai Prager and Sandra Reuter and Gershwin, {M. Eric}",
year = "2011",
month = "3",
doi = "10.1038/cmi.2010.68",
language = "English (US)",
volume = "8",
pages = "121--125",
journal = "Cellular and Molecular Immunology",
issn = "1672-7681",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Novel trends in celiac disease

AU - Matthias, Torsten

AU - Neidhöfer, Sandra

AU - Pfeiffer, Sascha

AU - Prager, Kai

AU - Reuter, Sandra

AU - Gershwin, M. Eric

PY - 2011/3

Y1 - 2011/3

N2 - Celiac disease (CD) is one of the most common food intolerances in developed world. It affects genetically susceptible individuals and has severe consequences if it remains undiagnosed. A disease known for more than a century, it is still the focus for experts from various fields of research and development. Geneticists, pathologists, immunologists, food engineers and dieticians share their knowledge and expertise to improve the conditions of CD patients. With new insights in the pathomechanism of gluten processing and antigen presentation in CD, it was possible to improve the diagnostic antigen mimicking the primary epitope in CD. These celiac neo-epitopes are comprised of a complex of gliadin peptides crosslinked with transglutaminase (tTg). They are an early diagnostic marker for CD which occurs up to 6 months earlier than classical markers known to miss a certain amount of CD patients.

AB - Celiac disease (CD) is one of the most common food intolerances in developed world. It affects genetically susceptible individuals and has severe consequences if it remains undiagnosed. A disease known for more than a century, it is still the focus for experts from various fields of research and development. Geneticists, pathologists, immunologists, food engineers and dieticians share their knowledge and expertise to improve the conditions of CD patients. With new insights in the pathomechanism of gluten processing and antigen presentation in CD, it was possible to improve the diagnostic antigen mimicking the primary epitope in CD. These celiac neo-epitopes are comprised of a complex of gliadin peptides crosslinked with transglutaminase (tTg). They are an early diagnostic marker for CD which occurs up to 6 months earlier than classical markers known to miss a certain amount of CD patients.

KW - celiac disease

KW - celiac neo-epitope

KW - diagnostic marker

KW - gluten

KW - tissue transglutaminase

UR - http://www.scopus.com/inward/record.url?scp=79952410828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952410828&partnerID=8YFLogxK

U2 - 10.1038/cmi.2010.68

DO - 10.1038/cmi.2010.68

M3 - Article

VL - 8

SP - 121

EP - 125

JO - Cellular and Molecular Immunology

JF - Cellular and Molecular Immunology

SN - 1672-7681

IS - 2

ER -